SPASM: Radiosurgery Treatment for Spasticity Associated With Stroke, SCI & Cerebral Palsy

Sponsor
Ohio State University (Other)
Overall Status
Recruiting
CT.gov ID
NCT06070233
Collaborator
Varian Medical Systems (Industry)
22
1
2
38.7
0.6

Study Details

Study Description

Brief Summary

A scientific study is being done to test a special treatment for people who have spasticity or tight muscles. This treatment is called "stereotactic radiosurgery dorsal rhizotomy." It uses very accurate beams of radiation to target certain nerves in the back to help loosen up the muscles. In this study, people are put into two groups by chance: one group gets the real treatment, and the other group gets a "fake" treatment that doesn't do anything. This fake treatment is called a "sham." Doing this helps make sure the study is fair and the results are true. After the people in the study get their treatment, the researchers will watch and see how they do. They will check if their muscles are less stiff and if they have any side effects. By looking at the results from both groups, the researchers can find out if the special treatment really helps people with spasticity. Patients who got the "fake" treatment will be eligible to receive the "real" treatment after 6 months.

Condition or Disease Intervention/Treatment Phase
  • Radiation: stereotactic radiosurgery (SRS) dorsal root rhizotomy radiomodulation
  • Other: Sham
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
22 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Randomized, Sham Controlled Trial of Dorsal Root Rhizotomy Stereotactic Radiosurgery Versus Standard of Care for Spasticity Associated With Stroke, Spinal Cord Injury & Cerebral Palsy
Anticipated Study Start Date :
Oct 11, 2023
Anticipated Primary Completion Date :
Dec 31, 2026
Anticipated Study Completion Date :
Dec 31, 2026

Arms and Interventions

Arm Intervention/Treatment
Sham Comparator: Sham Treatment

No intervention but can crossover after 6 months

Other: Sham
Patients will be simulated in the supine position in an immobilization apparatus deemed by the treating physician to be appropriate for the patient being able to comfortably maintain position for the duration of treatment. All patients will be simulated and treated using free breathing.

Active Comparator: SRS Treatment

Radiation: stereotactic radiosurgery (SRS) dorsal root rhizotomy radiomodulation
Patients will be simulated in the supine position in an immobilization apparatus deemed by the treating physician to be appropriate for the patient being able to comfortably maintain position for the duration of treatment. All patients will be simulated and treated using free breathing. Prescription dose is 50 Gy delivered in a single fraction to the target volume, prescribed to whatever isodose line produces optimal falloff (but not less than a 50% isodose line; dmax <100Gy) . All radiosurgery treatment will utilize the Varian Edge, Varian TrueBeam STx, or CyberKnife system

Outcome Measures

Primary Outcome Measures

  1. Change in Modified Ashworth Scale [6 months post treatment]

    Change in the 6-month post-treatment Modified Ashworth Scale (MAS) measure of spasticity, which ranges from 0 (no symptoms) to 4 (worst symptoms)

Secondary Outcome Measures

  1. Change in spasticity-related quality of life (SQoL-6D) [2 years post treatment]

    Change in spasticity-related quality of life 6-dimensions instrument (SQoL-6D) over two years post-treatment, where the scale ranges from 0 (worst quality of life) to 100 (best quality of life)

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Chronic spasticity refractory to medical management or in a patient who cannot receive appropriate medical management mediated by one or more spinal nerve roots

  • Age > 16 (if under 18, patients parents must sign consent).

Exclusion Criteria:
  • Inability to lie supine for simulation & treatment

  • Inability to visualize the target nerve on either CT or MRI imaging

  • Patients with confirmed pregnancy (all women of child-bearing age with intact uterus & ovaries will be required to undergo a pregnancy test prior to simulation)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ohio State University Wexner Medical Center Columbus Ohio United States 43210

Sponsors and Collaborators

  • Ohio State University
  • Varian Medical Systems

Investigators

  • Principal Investigator: Evan Thomas, MD/PhD, The Ohio State University Wexner Medical Center

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Evan Thomas, Assistant Professor, Radiation Oncology, Ohio State University
ClinicalTrials.gov Identifier:
NCT06070233
Other Study ID Numbers:
  • 2022H0425
First Posted:
Oct 6, 2023
Last Update Posted:
Oct 13, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 13, 2023